A reasonable chance it could cause serious harm or death.
Subpotent Drug: FDA analysis found product to be subpotent
| Distributed by / for | RLC Labs Inc. |
| NDC | 64727-5550-4 |
| Full product label | WP Thyroid, Westhroid Pure, 1/2 Grain (32.5 mg) Thyroid USP [Liothyronine (T3) 4.5 mcg, Levothyroxine (T4) 19 mcg], packaged in a) 30-count bottles (NDC 64727-5550-4), b) 90-count bottles (NDC 64727-5550-6), c) 100-count bottles (NDC 64727-5550-1), Rx only, Manufactured by: RLC Labs Phoenix, AZ 85024 |
| Recalling firm | RLC Labs Inc. |
| Distribution | Nationwide in the United States |
| Quantity | N/A |
| Recall initiated | 2020-08-25 |
| Report date | 2020-09-23 |
| Recall completed | 2023-11-08 |
| Recall number | D-1614-2020 |
| Classification | Class I |
| FDA status | Terminated |
| Origin on file | Phoenix AZ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗